EMEA-001884-PIP03-18
Key facts
| Active substance |
Hydrogen Peroxide
|
| Therapeutic area |
Dermatology
|
| Decision number |
P/0268/2019
|
| PIP number |
EMEA-001884-PIP03-18
|
| Pharmaceutical form(s) |
Cutaneous solution
|
| Condition(s) / indication(s) |
Treatment of common warts (verrucae vulgaris)
|
| Route(s) of administration |
Cutaneous use
|
| Contact for public enquiries |
Aclaris Therapeutics, Inc.
Tel. +1 484 540 6264 |
| Decision type |
RP: decision refers to a refusal on a proposed Paediatric Investigation Plan
|